Introduction
In the USA, sterilization in female or male is the most common contraceptive method (36% in 2008 versus 33.4% in 2011 to 2013) by sexually active couples. (Bartz and Greenberg, 2008; Daniels et al., 2014) In Belgium, this method is chosen by 8% of the couples, with an average of 14 035 vasectomies are performed yearly (RIZIV, 2015) . However some studies have shown that 3.4-7.4% of men who have undergone a vasectomy regret their decision and request reversal of sterilization, despite the low success rates of 30-60% (Bartz and Greenberg, 2008; Daniels et al., 2014; Bayingana et al., 2014; RIZIV, 2015) .
Despite adequate counseling prior to vasectomy, which generally includes the accompanying risks, the 80-85% success rate and the difficulties associated with the reversal procedure, changes in personal circumstances may result in regret and consideration of a reversal (Bartz and Greenberg, 2008; Michielsen and Beerthuizen, 2010; Hendry,1994; Howard, 1982) .
If there is a renewed child wish after vasectomy, couples may choose between surgical vasectomy reversal, i.e. vasovasostomy or vasoepididymostomy, or surgical sperm retrieval combined with an IVF/ICSI.
A number of factors have been shown to influence the probability of conception after vasectomy reversal. Some of these factors are known preoperatively, i.e. obstructive interval, prior male and/or female infertility, male and/or female age. Other factors, such as intraoperative vasal fluid characteristics, become clear only during surgery (Nagler and Jung, 2009) .
In this retrospective cohort study, we aimed to investigate the results of the vasectomy reversal procedure and to compare IVF/ICSI to reanastomosis.
Materials and Methods

Study design and patient flow
This retrospective study was performed in the Center for Reproductive Medicine of Universitair Ziekenhuis Brussel (Dutch speaking Brussels Free University in Belgium). From January 2006 to December 2011, 196 patients consulted our center for a renewed child wish after male sterilization.
After reviewing the medical records from these couples, 163 were ultimately included, with 33 being excluded (given that 30 couples were lost to follow-up and 3 women requested oocyte donation, Fig. 1 ).
Of the 163 included patients, 99 patients underwent microsurgical vasovasostomy by the same surgeon. This group was labeled the 'overall reanastomosis' group and was further divided into two subgroups, i.e. 'switchers' and 'primary reanastomosis'. The 'switchers' who underwent a reanastomosis but later switched to ART included 50 (50.5%) couples who switched to IVF/ICSI with sperm retrieval and 4 (4.04%) who couples underwent IUI, of whom 2 switched again to IVF/ICSI with sperm retrieval. The subgroup who underwent a reanastomosis procedure and did not switch to ART were labeled as the 'primary reanastomosis' group. The remaining group of 64 patients started immediately with surgical sperm retrieval and IVF/ICSI (the 'primary IVF/ICSI' group). All patients had a follow-up period of a minimum 57 months (range: 57-120 months).
The primary outcome for this study was the cumulative live birth rate. The choice between surgical reversal or IVF/ICSI with sperm retrieval was made after counseling and explanation of both options and was based on patient's and physician's preference.
Reversal procedure
At the time of the pre-operative consultation, information regarding the reversal procedure was given as for the possibility of performing a testicular sperm extraction (TESE) during the same procedure. The advantage is that testicular sperm can be frozen and used when a switch to IVF/ICSI is necessary or requested without undergoing a secondary intervention.
The procedure is performed under general anesthesia. High bilateral vertical scrotal incisions are made depending where the defect is palpable. Both ends of the vas deferens were dissected.
In the next step, the vas needed to be prepared and length needed to be created to become a tension-free anastomosis; this is called mobilization of the vas. This mobilization is done carefully without stripping the outer vasal sheath with its vasal blood supply.
For precise connection of the vasal ends, both ends were transected at a 90°angle with a scalpel, followed by visual inspection of the following layers of the vas: the inner mucosal layer, the muscularis (with a middle circular layer and an inner and outer longitudinal layer) and the vasal sheath (which surrounds the vas and contains its blood supply).
For the anastomosis, the mucosa of both ends were approximated after verifying the patency of both ends.
Both ends were finally connected by using: one-layer, two-layer or microdot multilayer techniques. Whenever some traction was present on the vas, the one-layer technique was performed. In the absence of any traction, a two-layer technique was preferred, where one inner layer of sutures close the mucosa and another outer layer of sutures was performed to close the seromuscular layer. In these techniques, our center performs a variant of the microdot principle, which was first described by Goldstein et al. (1998) , in which the lumen of the vas deferens are marked with methylene-blue at 3, 6, 9 and 12 o'clock, to approximate the ends more precisely. This procedure is performed with a Leica surgical microscope at 200 mm magnification (Leica systems, Diegem, Belgium).
Intraoperative harvesting of testicular sperm was combined with the reanastamosis by performing an unilateral TESE during the procedure.
Postoperatively, the patient performed absolute bed rest for 24 h in hospital, followed by 1 week of work restriction and two weeks of no sport or heavy activity. The use of scrotal support was also recommended until the disappearance of local discomfort. After 2 months, a follow-up consultation was planned with the surgeon and a semen analysis was performed.
Intrauterine insemination
Four couples performed a reanastomosis procedure and then later IUI. A minimum of three and a maximum of five attempts were performed. Two of these couples later switched to IVF/ICSI after three months.
IVF/ICSI
A total of 64 couples started directly with a IVF/ICSI treatment. The choice of stimulation protocol was performed on case-by-case basis according to clinician's preference and patient characteristics. An antagonist protocol was used in 54.7% (35 out of 64) of the cases. The standard protocol was previously described in detail elsewhere (Blockeel et al., 2012) . Patients were monitored by serum hormones oestradiol and progesterone and by vaginal ultrasound scans. As soon as three follicles with a diameter of ≥17 mm were visualized on a pelvic ultrasound scan, 5000 or 10 000 IU hCG (Pregnyl ® ; MSD; New Jersey, USA) was administered to trigger final oocyte maturation, followed after 36 h by the transvaginal aspiration of the cumulus oocyte complexes (COCs). In 29 patients (45.3%) of the primary IVF/ICSI group, an agonist protocol was used. The long GnRH-agonist protocol was used in 71.4% of the agonist cases and the short agonist protocol was used in 28.6% of the agonist cases.
In general, either IVF, ICSI or IVF versus ICSI were performed, depending on the patients characteristics and physicians preference. Whenever, surgical sperm retrieval was necessary by either fine needle aspiration (FNA) or testicular sperm extraction (TESE), ICSI was performed.
In the majority of cases, a single embryo was transferred five days after oocyte retrieval. For luteal phase support, 200 mg progesterone (Utrogestan ® ; Besins International, Paris, France) was given intravaginally three times daily, starting on the day after oocyte retrieval until seven weeks of pregnancy.
Sperm retrieval
The 'primary IVF/ICSI' pathway included all cases in which no reanastomosis was performed or in which the reanastomosis of the vas deferens failed. In these cases, we retrieved sperm by FNA or TESE or a percutaneous epididymal sperm aspiration (PESA) before an ICSI treatment. In 40.8% of the IVF/ICSI switchers, ejaculated spermatozoa were used for injection.
Statistical analysis
The primary outcome of this retrospective study was delivery resulting in at least one live birth in patients with primary IVF/ICSI compared to patients with primary reanastomosis. The delivery of one or more children was given the same weight. The first delivery was the endpoint of this study, so when this was reached, patients were not re-enrolled. HCG levels above 20 IU/l indicated pregnancy. Clinical pregnancy was defined as the observation of fetal cardiac activity on ultrasonography at seven weeks of gestation. Each miscarriage was included in the count of the pregnancies, until the patients reached the final live birth delivery outcome.
We provided two methods to estimate the effectiveness of each treatment according to the time period. The first approach calculated the outcome by dividing the number of women achieving live birth delivery up to a predetermined time period (numerator) by the total number of women who started one of both treatments (denominator). The outcome measure associated with this approach is referred to as the 'Crude cumulative delivery rate' (crude CDR). The other method estimated the cumulative live birth delivery rate after a specified number of months (time) using lifetable analysis, by taking into account the effects of drop-outs (censoring). The outcome measure associated with this method is referred to as the 'Expected CDR' (expected CDR). These methods have been extensively described in previous reports of our institution (De Brucker et al., 2009 . The outcome measures of both methods cannot be readily compared, as these outcomes cannot be transformed to a similar unit. The first method provides a conservative estimate of outcome because it does not take into account the censoring.
Log-rank tests were used to compare the crude CDRs (curves) and a multivariate analysis was performed by Cox's proportional hazard model. Apart from comparisons between treatment options ('primary IVF/ICSI' versus 'primary reanastomosis'), CDRs were compared between the 'primary IVF/ICSI' pathway and 'overall reanastomosis'. As mentioned, 'primary reanastomosis' patients and 'switchers' were included in the'overall reanastomosis' group (De Brucker et al., 2009) .
Computational procedures were performed using Statistics Package for Social Sciences for Windows version 16 (SPSS Inc., Chicago, IL, USA).
Ethics approval
Retrospective studies performed on anonymous patient data must undergo a review by the local Ethical Committee, according to Belgian legislation. The Ethical Committee of 'Universitair Ziekenhuis Brussel' accepted this study. Table I provides the baseline characteristics of the 164 patients included in this study. The different pathways with their outcome are shown in Fig. 2 .
Results
Patient characteristics
The surgical characteristics are displayed in Table II . After reanastomosis, sperm was found in the ejaculate in 79.3% of the men.
The reasons for the reversal in the overall reanastomosis pathway group are shown in Table III . Table IV shows the CDR, including drop-out rates, number of pregnancies, miscarriages and deliveries according to time of all different pathways. There were 64 women who tried to get pregnant by choosing to perform ART immediately without a vasovasostomy procedure. Overall in this pathway, there were 28 deliveries including three twin pregnancies and one vanishing twin pregnancy. There was one delivery of <37 weeks of gestation (36.2 weeks, which was a twin pregnancy) and four deliveries at 37 weeks of gestation.
CDR in primary IVF/ICSI pathway
The crude and expected CDRs for this pathway were respectively 43.8 and 51.6% 21 months after the start of IVF/ICSI cycles, with a plateau being reached in the fifth three-month period. The mean number of cycles was 2.4 ± 1.6 (range: 1-7) cycles in this group.
CDR in overall reanastomosis pathway
In this study, 99 women tried to get pregnant after a vasectomy reversal procedure of their partner. The crude and expected CDRs for this pathway were respectively 49.5 and 51.2% 21 months after the vas reanastomosis, at 12-18 months there is an upsweep of deliveries (Table IV) .
CDR in primary reanastomosis pathway
In the primary reanastomosis pathway 45 women tried to get pregnant spontaneously after a vasovasostomy of their partner. Overall, there were 18 deliveries including one delivery of <37 weeks of gestation (5.5%). There were no twin pregnancies. The crude and expected CDRs for this pathway were 40.0 and 42.0% 21 months after the vas reanastomosis (Table IV) .
CDR in switchers pathway
Four couples switched after vasovasostomy to intrauterine insemination, and the mean interval for this switch was 11.5 months (range: 8-16 months) with a mean of four attempts (range: 3-5 months). The mean interval to switch to ART in the population of 54 patients was 13.7 months (range: 0-41 months). In this group there were 31 deliveries of which five were twins. The crude and expected CDRs for the switchers were 57.4 and 59.0% 21 months after the vas reanastomosis (Table IV) .
Primary IVF/ICSI pathway versus primary reanastomosis
We found no statistical differences when comparing the CDRs observed in the primary IVF/ICSI and primary reanastomosis pathway ( Table IV) . Despite that, a trend where the primary IVF/ICSI pathway had in general higher crude CDRs when compared to the primary reanastomosis pathway is depicted in Fig. 3 . Both strategies reach a plateau 12-18 months after the start of the interventions. Figure 4 shows the expected CDRs for both pathways, which takes the drop-out rate into consideration. Here the difference between both groups was more remarkable, but the trend was similar (51.6% for IVF/ICSI versus 42.0% reanastomosis). Values represent mean ± SD and the range (minimum-maximum). The T test between the primary IVF/ICSI and overall reanastomosis gave the P-value in this table. *NS: not significant.
Primary IVF/ICSI pathway versus switchers pathway
By comparing the CDRs for the primary IVF/ICSI versus switchers pathway, we found no statistical significant differences. After 21 months, the crude CDR of the switchers surpassed the primary IVF/ ICSI pathway, as displayed in Fig. 5 . For this first pathway, the time started at the point of the vasovasostomy procedure. In the switchers pathway, the mean number of cycles was 2.5 ± 2.1 cycles before stopping the treatment. The sperm retrieval in this group was in 36.7% by masturbation (fresh), 4.1% by TESE fresh, 49.0% by TESE frozen and 6.1% by FNA. In the primary IVF/ICSI pathway, the mean number of cycles was 2.4 ± 1.6. In 73.4% (47 out of 64) of this group, an FNA was performed to obtain fresh sperm, 23.4% underwent a biopsy where sperm were used fresh (40.0%) or frozen (60.0%) and in 3.1% a PESA was performed.
Primary IVF/ICSI pathway versus overall reanastomosis pathway
In Fig. 6 , the CDRs of the primary IVF/ICSI pathway and the overall reanastomosis pathway, where the switchers are included, are presented. When comparing these pathways, again there way no significant difference in treatment options.
Time to pregnancy and delivery
Time to pregnancy and time to delivery is an interesting factor to take into consideration when counseling patients. Table V shows the data in this study group. When the couple chose immediate IVF/ICSI, the time to pregnancy was significantly shorter than the overall reanastomosis pathway, respectively 8.2 versus 16.3 months. As expected, the time to delivery is significantly different between both groups as well.
Discussion
When couples have a renewed child wish after vasectomy, two treatment options are possible, i.e. surgical vasectomy reversal and ART with (surgical) sperm retrieval. Knowing the probability of delivering a baby after each fertility treatment is important for both the candidate couples and their fertility specialist. This is a very objective tool to measure the success rate long term. The vasectomy reversal procedure is more cost-effective than ART (Meng et al., 2005) . It is a mild invasive procedure for the male compared to the invasive procedure with associated complications in both partners undergoing a IVF/ICSI treatment with sperm retrieval (van Dongen et al., 2012; Deck and Berger, 2000) . IVF/ICSI procedures are well developed and are supported by a great medical evidence to rely on. Therefore some centers prefer to start with ART instead o reanastomosis. The goal of this study was to gather more information on vasectomy reversal to improve counseling of patients with their renewed child wish.
The mean obstructive interval was 9.63 years ± 6.1 (range: 1-30 years), which corresponds to others studies, i.e. 9.4 years ± 5.3 (Gerrard et al. 2007 ) and 10.0 years ± 5.4 (Silber and Grotjan, 2004 and, conversely, somewhat higher than found in the meta-analyses of Scovell et al. (7.1 years) and Heller et al. (7.2 years) . The mean age of the male patient at time of the reversal procedure was 44.4 years ± 6.7 (range: 31-62 years), which is higher than those found in the reviews of Scovell et al. (2015) (37.8 years) and Herrel et al. (2015) (38.9 years). In our study, we found a crude CDR of 49.5% in the overall reanastomosis pathway, 40.0% in the primary reanastomosis and 57.4% in the switchers subgroup. The expected CDR in this overall group was 51.2%. Because only 36.1% of women had proven their fertility potential by their prior parity, it was difficult to estimate the CDR prior to the study. Detailed CDRs after reanastomosis procedure have not, to the best of our knowledge, been reported in previous studies.
Pregnancy rates, on the other hand, are better documented. Specifically, Van Dongen et al. reported after vasectomy reversal an overall pregnancy rate of 58.6% in a study group of 162 couples, including the natural conceiving (44.4%) and those using ARTs (14.2%). Gerrard et al. examined the female age factor and reported a pregnancy rate of 54.3% (n = 294). In this publication, only those who conceived naturally were counted. Scovell et al. reported in their meta-analysis that, because of inconsistent reporting, analysis of outcomes (e.g. pregnancy) was not possible. Chiang (1996) reported a pregnancy rate of 36.8% within the first year of follow-up (n = 38). Silber et al. reported a pregnancy 89.6% and delivery in 84.7% after vasovasostomy (n = 575). A meta-analysis by Herrel et al. (2015) had mean pregnancy rates of 73.0%, which is higher than our CDR. A previous report from our center reported that the crude CDR for fresh donor ICSI after six cycles was 51.0% and the expected CDR was 59.0%. This is slightly higher than the crude and expected CDR in our primary IVF/ICSI pathway, respectively 43.8 and 51.6%. This might be due to the small number of patients in our pathway (n = 64).
As known from previous literature, our pregnancy outcomes achieved using fresh or frozen-thawed spermatozoa were comparable in this cohort of men with obstructive azoospermia (Janzen et al. 2000) . In the switchers pathway, the majority (49.0%) underwent a TESE and the achieved spermatozoa were all frozen-thawed afterwards. In contrast, the majority of the primary IVF/ICSI pathway (73.4%), performed a FNA and fresh sperm cells were used for the IVF/ICSI. Although different sperm retrieval methods were used, the results after 21 months remained similar.
The question of whether one should advise couples to attempt a reanastomosis or to go directly to IVF/ICSI treatment remains unresolved. If we compare the two pathways there was a visible trend, where the primary IVF/ICSI pathway had, in general, higher crude CDRs than the primary reanastomosis pathway. Specifically, 21 months after the start of the treatment, the crude CDRs were 43.8 and 40.0%, respectively. However, these difference were not statistically significant and both reached a plateau 12-18 months after the start of interventions. Given that time-to pregnancy is of paramount importance, especially in older female patients, one should strive to obtain the best result in a shortest timeframe. In case of advanced female age, we would thus advise to start immediately with IVF/ICSI treatment and surgical sperm retrieval. In the reanastomosis group with later switches to IVF/ICSI, although the success rate may be comparable after 18 months, this came at the cost of a significantly longer waiting period.
The strengths of our study include the choice of live birth delivery as the outcome of primary interest and the use of well-validated methods to present both crude and expected cumulative delivery. Furthermore, all vasovasostomies were performed by the same surgeon, thus minimizing surgeon-related bias. Conversely, the limitations of this study are its retrospective nature and the rather small amount of patients included.
In most cases, the reason for the renewed child wish is a new relationship with another woman. The majority of those women did not have a prior pregnancy. The chance of pregnancy is not only related to the male factor but also to the female factors, which are sometimes difficult to distinguish.
Finally, other factors that need to be investigated are the costeffectiveness of both treatment options and the influence of the sperm quality after the reanastomosis.
Conclusion
The vasectomy reversal procedure is a good treatment option when there is a renewed child wish after vasectomy.
We can propose that couples can switch to ART to augment their pregnancy chances if in 18 months after the reanastomosis procedures couples have not achieved a spontaneous pregnancy. This is a way to delay invasive ART treatments and to maximize the chance of success. Conversely, if the female partner is older than 35 years old, it may be more prudent to switch faster or to start immediately with sperm retrieval and IVF/ICSI. Primary IVF/ICSI (n = 64) 8.2 ± 13.0 14.1 ± 6.5
Overall reanastomosis (n = 99) 16.3 ± 11.3 24.6 ± 11.0
Primary reanastomosis (n = 45) 9.1 ± 7.9 17.9 ± 8.0
Switchers (n = 54) 19.2 ± 11.3 27.5 ± 10.9
